Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Anne Marie Horneman has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 17, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14806546

NOVEL NEUROKININ 1 RECEPTOR ANTAGONIST COMPOUNDS II

IPC classification:
A61P 17/04, A61K 31/4985, C07D 487/04
Agent:
Anne Marie Horneman, Leo Pharma A/S
Status:
The patent has been granted

Please Sign in to use this feature